Quantitative speed-resolved perfusion and oxygen saturation
In the PF 6000 EPOS system, laser Doppler flowmetry (LDF) and diffuse reflectance spectroscopy (DRS) have been successfully integrated, enabling accurate measurements of blood flow and oxygen saturation in the microcirculation. This enables unexplored possibilities to study and understand complex disease progressions such as severe diabetes and other physiological events involving blood flow and oxygenation.
The principal advantage of this novel technology is that it presents blood perfusion in absolute units, not only qualitatively as when using a standard laser Doppler. Furthermore, it distinguishes different speeds within the blood flow—speed-resolved perfusion. For example, it enables the ability to differentiate slow nutritive flow, essential for all living cells in the body, from faster flow that only has the purpose of transportation. In addition, it is possible to study the correlation between flow speed and red blood cell (RBC) oxygen saturation, revealing information about oxygen delivery and uptake into the surrounding tissue. To estimate the microcirculatory parameters, a unique model-based analysis of multimodal measurements is employed. The multilayered tissue model is adapted to the measured signals in real time and the following parameters are obtained from the adapted model:
- RBC oxygen saturation (%)
- RBC tissue fraction: gram RBC / 100 gram tissue (%)
- Speed-resolved perfusion: gram RBC / 100 gram tissue × mm/seconds (% RBC x mm/second). Three different speed regions: < 1 mm/second, 1 to 10 mm/second, and > 10 mm/second
- Measurement depth (mm)
The figures show an example of the output parameters during a post-occlusive reactive hyperemia test on forearm skin.
Example of post-occlusive reactive hyperemia measurement on forearm skin with 5 min. baseline, 5 min. brachial occlusion (250 mmHg, shaded area) and 5 min. reperfusion stage.
(A) Speed-resolved perfusion
(B) RBC oxygen saturation and RBC tissue fraction
PF 6000 EPOS system consists of a main unit (PF 6000 Main Unit) equipped with a spectroscopy unit (PF 6060 Spectroscopy Unit) and a laser Doppler monitoring unit combined with temperature control (PF 6010 LDPM/Temp Unit). In addition, a dedicated fiber-optic probe that integrates the DRS and LDF modalities is required. The probe includes heating functionality. Furthermore, a pressure unit (PF 6050 Pressure Unit) can optionally be added to accurately study post-occlusive hyperemia responses, and a tcpO2 unit (PF 6040 tcpO2 Unit) can be added for simultaneous transcutaneous oxygen pressure recordings. A dedicated software (EPOS Manager) is available for operation and data evaluation.
Please note that this instrument is intended for research purposes in USA and China. PF 6000 EPOS is planned for launch in Europe in 2020.
The PF 6000 EPOS system was developed in cooperation with researchers at the department of biomedical engineering at Linköping University (Sweden) supported by VINNOVA – Sweden’s innovation agency.